1X95

Solution structure of the DNA-hexamer ATGCAT complexed with DNA Bis-intercalating Anticancer Drug XR5944 (MLN944)

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	1-4mM DNA oligonucleotides; MLN944/DNA 1:1 ; 50mM sodium phosphate buffer at pH 7; 90% H2O, 10% D2O	90% H2O/10% D2O	50mM sodium phosphate buffer	7.0	ambient	298
2	2D NOESY	1-4mM DNA oligonucleotides; MLN944/DNA 1:1 ; 50mM sodium phosphate buffer at pH 7; 90% H2O, 10% D2O	90% H2O/10% D2O	50mM sodium phosphate buffer	7.0	ambient	298
3	DQF-COSY	1-4mM DNA oligonucleotides; MLN944/DNA 1:1 ; 50mM sodium phosphate buffer at pH 7; 90% H2O, 10% D2O	90% H2O/10% D2O	50mM sodium phosphate buffer	7.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
molecular dynamics		XwinNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (fewest violations)

Additional NMR Experimental Information
Details	This structure was determined using standard 2D homonuclear techniques.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	XwinNMR	3.5
2	data analysis	Sparky	3.1	Goddard T.D. ; Kneller, D. G.
3	refinement	X-PLOR	3.851	Brunger, A.T.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.